US FDA approves Precigen's immunotherapy for rare respiratory disease

reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-precigens-immunotherapy-rare-respiratory-disease-2025-08-15

This story appeared on reuters.com, 2025-08-15 11:19:06.220000.
The Entire Business World on a Single Page. Free to Use →